Novan Announces Statistically Significant Phase 2 Clinical Trial Results for SB206
Nov 29, 2016 11:05 am UTC| Business
Number of Patients with Complete Clearance of Genital WartsProvides Clinical Evidence of Nitric Oxide Anti-Viral Activity Against HPV Company Plans End-of-Phase 2 Meeting for First Half of 2017 MORRISVILLE, N.C., Nov. ...
Nov 29, 2016 11:00 am UTC| Business
BETHLEHEM, Pa., Nov. 29, 2016 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it will begin fulfilling a contract to supply a...
Nov 29, 2016 11:00 am UTC| Business
IRVINE, Calif., Nov. 29, 2016 -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces that its...
Nov 29, 2016 11:00 am UTC| Business
BURLINGTON, Mass. and SAN FRANCISCO, Nov. 29, 2016 -- Decision Resources Group (DRG), a leading provider of proprietary data products and solutions to the healthcare industry, and Zephyr Health, the leading...
Nov 29, 2016 11:00 am UTC| Business
China ranks first, U.S. second in generating significant GDP from built assetsIf U.S. invests $1 trillion in infrastructure improvements, U.S. GDP’s return on built assets could improve to 33 percent over 10...
ICSA Labs Affirms Radware’s DDoS Mitigation Software and Testing Methodology
Nov 29, 2016 11:00 am UTC| Business
MAHWAH, N.J., Nov. 29, 2016 -- Radware® (NASDAQ:RDWR), a leading provider of cyber security and application delivery solutions ensuring optimal service levels for applications in virtual, cloud, and software-defined...
Nov 29, 2016 11:00 am UTC| Business
- Oragene®●Dxsaliva collection kits to provide reliable DNA samples for Helix - BETHLEHEM, Pa., Nov. 29, 2016 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood